Your browser doesn't support javascript.
loading
Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.
Tigyi, Gabor J; Johnson, Leonard R; Lee, Sue Chin; Norman, Derek D; Szabo, Erzsebet; Balogh, Andrea; Thompson, Karin; Boler, Alyssa; McCool, W Shannon.
Afiliación
  • Tigyi GJ; Department of Physiology, University of Tennessee Health Science Center Memphis, Memphis, TN 38163 gtigyi@uthsc.edu.
  • Johnson LR; RxBio Inc. Memphis, TN 38163.
  • Lee SC; Research Division Veterans Affairs Medical Center, Memphis, TN 38104.
  • Norman DD; Department of Physiology, University of Tennessee Health Science Center Memphis, Memphis, TN 38163.
  • Szabo E; RxBio Inc. Memphis, TN 38163.
  • Balogh A; Department of Physiology, University of Tennessee Health Science Center Memphis, Memphis, TN 38163.
  • Thompson K; Department of Physiology, University of Tennessee Health Science Center Memphis, Memphis, TN 38163.
  • Boler A; Research Division Veterans Affairs Medical Center, Memphis, TN 38104.
  • McCool WS; Department of Physiology, University of Tennessee Health Science Center Memphis, Memphis, TN 38163.
J Lipid Res ; 60(3): 464-474, 2019 03.
Article en En | MEDLINE | ID: mdl-30692142
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores del Ácido Lisofosfatídico / Descubrimiento de Drogas Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores del Ácido Lisofosfatídico / Descubrimiento de Drogas Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article